Tag: research
-
Revive Therapeutics (RVV.C) takes on long covid with new phase 2/3 FDA protocol
Allow me to back into the lede a bit here. THE STORY OF ROCKERFELLER VS THE WORMS In the early part of the 20th century, the American South was known colloquially as ‘the hookworm belt.’ Hookworms are parasites that like a human host. They corkscrew into your feet when you walk by them barefoot, travel…
-
Canntab (PILL.C) yeets another patent for hard-pressed, long release cannabis pills
I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature space that more and more adults are making use of, and that is free to innovate, free to be excellent, free to market itself properly, and…
-
Sproutly: The cannabis monster in the making you’ve never heard of
I hated him. My head was pounding. Sick for a week. Struggled into the Sproutly boardroom convinced I looked like eighteen miles of bad road and my voice sounded like Jar Jar Binks in a wind tunnel. The view from the office was magnificent, but I couldn’t focus on it, or anything. I was in…
-
Canabo Medical’s (CMM.V) gangbuster rookie season
In 1979 a 160-pound teenager from a small town in Ontario entered the National Hockey League (NHL). A respected scout predicted that he was “too small, slow and weak” to succeed in the NHL. In his first 6 months in the league, playing for the Edmonton Oilers, he scored about 111 points. It might be…
-
Veritas Pharma (VRT.C) lays its cards on the table
When I was running the editorial show at Stockhouse, I had reason to look over a lot of messageboards for a wide variety of public companies. Almost without fail, you could bet that any given messageboard would be faced with two problems. This is how good companies end up with bad stock charts. They lose…
